Gujarat Terce Laboratories (BOM:524314) EV-to-Revenue : 0.93 (As of May. 24, 2024)

View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gujarat Terce Laboratories's enterprise value is ₹450.7 Mil. Gujarat Terce Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹486.6 Mil. Therefore, Gujarat Terce Laboratories's EV-to-Revenue for today is 0.93.

The historical rank and industry rank for Gujarat Terce Laboratories's EV-to-Revenue or its related term are showing as below:

BOM:524314' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.13 Med: 0.31 Max: 1.03
Current: 0.92

During the past 13 years, the highest EV-to-Revenue of Gujarat Terce Laboratories was 1.03. The lowest was 0.13. And the median was 0.31.

BOM:524314's EV-to-Revenue is ranked better than
81.48% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs BOM:524314: 0.92

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), Gujarat Terce Laboratories's stock price is ₹54.86. Gujarat Terce Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹65.51. Therefore, Gujarat Terce Laboratories's PS Ratio for today is 0.84.

Gujarat Terce Laboratories EV-to-Revenue Historical Data

The historical data trend for Gujarat Terce Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories EV-to-Revenue Chart

Gujarat Terce Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

0.23

0.19

0.34

0.61

0.38

Gujarat Terce Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.31	0.38	0.45	0.48	0.43

Competitive Comparison of Gujarat Terce Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Terce Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's EV-to-Revenue falls into.

Gujarat Terce Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Gujarat Terce Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	450.723	/	486.561
	=	0.93

Gujarat Terce Laboratories's current Enterprise Value is ₹450.7 Mil.
Gujarat Terce Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹486.6 Mil.

Gujarat Terce Laboratories (BOM:524314) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Gujarat Terce Laboratories's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	54.86	/	65.51
	=	0.84

Gujarat Terce Laboratories's share price for today is ₹54.86.
Gujarat Terce Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹65.51.

Gujarat Terce Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gujarat Terce Laboratories (BOM:524314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015

Website

https://www.gujaratterce.in

Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines